Skip to content
Bleeding Disorders News logo Newsletter
Newsletter
  • Bleeding Disorders News on Facebook
  • Bleeding Disorders News on Instagram
  • Conditions
    Immune thrombocytopenia
    • ITP overview
    • ITP treatment
    Thrombotic thrombocytopenic purpura
    • TTP overview
    • TTP treatment
    Von Willebrand disease
    • Von Willebrand disease overview
    • Von Willebrand disease treatment
    Hemophilia
  • Community
    Columns
    • One Drop at a Time — Shalana Jordan
  • News
  • Quizzes
    Managing bleeding disorders
    ITP basics
  • What can we help you find today?

    • Bleeding Disorders News on Facebook
    • Bleeding Disorders News on Instagram

Corticosteroids for immune thrombocytopenia

Last updated July 14, 2025, by Lindsey Shapiro, PhD
✅ Fact-checked by Inês Martins, PhD

Usage
Side effects

 

What are corticosteroids?

Corticosteroids, sometimes called steroids, are powerful immune-suppressing medications that are often the first-line treatment for immune thrombocytopenia (ITP).

In ITP, the immune system mistakenly attacks and destroys healthy platelets, the cell fragments that help blood clot and stop bleeding after an injury. This leaves patients more prone to easy or excessive bleeding.

Corticosteroids are lab-made medications that mimic cortisol, a naturally occurring hormone produced by the adrenal glands, which sit atop the kidneys. Cortisol plays a key role in regulating inflammation and immune responses.

By imitating cortisol, corticosteroids help reduce the immune system’s attack on platelets, thereby increasing platelet levels and lowering the risk of bleeding.

The specific corticosteroids used for ITP work by binding to glucocorticoid receptors. For this reason, they are also commonly referred to as glucocorticoids.

When are corticosteroids used for immune thrombocytopenia?

Corticosteroids are the standard first-line treatment for people with ITP. They are typically started when platelet counts fall below a certain threshold, putting a person at risk of significant bleeding. But other factors, such as a person’s age, overall health, and the severity of symptoms, are also factored in when deciding to begin treatment.

There are various types of corticosteroids, but the main ones used for ITP include:

  • prednisone (or its active form, prednisolone)
  • dexamethasone
  • methylprednisolone.

Treatment guidelines generally recommend people with ITP receive short courses of oral corticosteroids to help raise platelet levels. These medications are then tapered off over a period of days to weeks.

Prednisone and dexamethasone are the most commonly used oral options. The specific treatment plan depends on platelet responses, side effects, and individual clinical factors.

Because oral corticosteroids can take some time to start working, some patients may receive them via infusions into the bloodstream (intravenously) to kickstart a faster response. This may be needed in urgent cases, for instance, when platelet counts are dangerously low or if the person is experiencing severe or critical bleeding. Methylprednisolone or dexamethasone are often used for this purpose.

In general, current guidelines recommend steroids be used for a short duration of six weeks or less in adults, and seven days or less in children. Longer use is not believed to offer additional benefits and may increase the risk of serious side effects.

While first-line steroids can push ITP into remission, where platelet counts are stable and the risk of bleeding is low, relapses are common after tapering, and less than 30% of patients are thought to achieve sustained remission after receiving steroids alone.

A poor response to corticosteroids or repeated relapses may prompt the need for second-line treatments, which work to raise platelet levels through other mechanisms.

Corticosteroid side effects

While there are numerous benefits of corticosteroids for ITP, most people on these treatments experience side effects, some of which can be serious. Corticosteroids side effects are particularly likely when the medications are used at high doses and for extended periods of time.

Specific side effects can vary depending on the corticosteroid type and dosage, but some common side effects include:

  • infections
  • weight gain
  • skin changes
  • growth delays in children
  • high blood pressure
  • sleep and mood disturbances
  • muscle weakness and bone thinning.

Because corticosteroids mimic the natural hormone cortisol, the body responds by decreasing its own cortisol production. If corticosteroids are stopped suddenly, before the body resumes its usual cortisol production, withdrawal symptoms may occur and could include:

  • severe fatigue
  • weakness
  • body aches
  • joint pain
  • nausea and appetite loss
  • irritability or mood swings.

In rare cases, a sudden drop in cortisol levels can lead to a serious complication called adrenal crisis, which can be life-threatening.

To avoid withdrawal symptoms, corticosteroids are gradually tapered off rather than stopped abruptly. People with ITP should never stop using corticosteroids without first consulting their healthcare provider about how to do so safely.


Bleeding Disorders News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Recent Posts

  • Dental procedures may lead to bleeding in VWD, hemophilia
  • High LDH may signal mortality risk in immune-mediated TTP
  • Unraveling mysterious symptoms: My ITP diagnosis
  • Doptelet, Doptelet Sprinkle for pediatric ITP win FDA approval
  • Hormonal therapy does not seem to lighten heavy periods in VWD


Related articles

  1. A person holding a toothbrush grins amid images of teeth and dental floss.
    August 1, 2025 News by Marisa Wexler MS NEWS

    Dental procedures may lead to bleeding in VWD, hemophilia

  2. July 30, 2025 by Margarida Maia, PhD NEWS

    High LDH may signal mortality risk in immune-mediated TTP

  3. July 29, 2025 Columns by Shalana Jordan

    Unraveling mysterious symptoms: My ITP diagnosis

  4. The word
    July 28, 2025 News by Margarida Maia, PhD NEWS

    Doptelet, Doptelet Sprinkle for pediatric ITP win FDA approval

  5. Illustration of red blood cells.
    July 25, 2025 News by Michela Luciano, PhD NEWS

    Hormonal therapy does not seem to lighten heavy periods in VWD

  6. A pregnant woman stands holding a stuffed toy and cradling her belly.
    July 23, 2025 News by Lindsey Shapiro, PhD NEWS

    Diagnosing, treating TTP promptly improves pregnancy outcomes

Swipe left to view more
Bionews logo Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

  • Bleeding Disorders News on Facebook
  • Bleeding Disorders News on Instagram
Copyright © 2013-2025 All rights reserved.